EBioMedicine is the premium gold open access venue for translational biomedical research. The journal is dedicated to publishing original research that elucidates, or aims to modify, disease pathways and mechanisms-with the goal of advancing our knowledge in any biomedical discipline with relevance to human health. 

We publish papers investigating the basic determinants of human health and disease, the discovery and characterization of new therapeutic targets and treatments, and the identification of biomarkers and diagnostic tools which may help researchers and clinicians better understand and monitor disease. EBioMedicine covers the whole spectrum of biomedical research, from preclinical studies with clear human relevance, through to proof-of-concept studies and clinical trials. The journal will also publish relevant reviews, commentaries and opinion pieces. 

We aspire to catalyse dialogue and collaboration between basic scientists, clinical researchers and healthcare professionals, enhance the accessibility and applicability of basic research findings for health professionals, and promote a better understanding of clinical challenges for biomedical researchers. 

Editorials
Comment
Correspondence
World Reports and News
Perspectives
Article
Clinical Picture
Commissions
Health Policy
Personal View / Viewpoint
Reviews
Seminar
Series
Therapeutics

Editors-in-Chief
Dr. Duc H. Le
Dr. Duc H. Le
UK Editor-in-Chief
Dr. Julie Stacey
Dr. Julie Stacey
US Editor-in-Chief
Senior Editors
Dr Claudia Schaefer
Dr Claudia Schaefer
US Senior Editor
Dr Daniel Stuckey
Dr Daniel Stuckey
UK Senior Editor
Editorial Assistant